ARCpoint to Host Conference Call for Q2 2024 Financial Results
ARCpoint Inc. (TSXV: ARC) is set to hold a conference call to discuss the Company’s financial results for the second quarter ending June 30, 2024. This call will also cover new opportunities arising from a recent transaction. It is scheduled for 4:45 PM Eastern time.
Conference Call Details
Here are the dial-in details for the conference call:
Canada / USA Toll Free: 1-844-763-8274
International Toll: +1-647-484-8814
Participants are encouraged to join about 5-10 minutes before the call begins.
Key Developments and Business Expansion
John Constantine, President and CEO of ARCpoint, emphasized the significant progress the Company has made in expanding its business and distribution network, particularly through the implementation of the MyARCpointLabs technology platform. This advancement was further highlighted by a recent partnership with Any Lab Test Now and the formation of CRESSO Brands.
Joint Venture with Any Lab Test Now
On August 20, 2024, ARCpoint announced a key transaction with Any Lab Test Now (ALTN), resulting in the creation of a joint venture named CRESSO Brands, LLC. This collaboration merges the franchise operations of both companies, establishing the largest franchise network for diagnostic services in the U.S. at the time of the announcement.
Founded in 1992, ALTN has over 235 franchise locations, offering direct access to a wide range of lab testing services. The joint venture aims to strengthen the operational capabilities of ARCpoint and its franchisees.
Leveraging MyARCpointLabs
John Constantine highlighted the significance of utilizing the MyARCpointLabs platform to drive business to CRESSO franchisees and to broaden the Company’s distribution network through new partnerships. This platform is designed to facilitate connections between franchisees and healthcare consumers, ultimately improving service delivery.
2024 Q2 Financial Overview
As of June 30, 2024, ARCpoint reported notable improvements in cost reduction compared to the previous year. The financial results indicate the Company’s enhanced expense management and operational efficiency.
Q2 Financial Highlights
- Total revenues for Q2 2024 reached $1.6 million, a slight increase from $1.5 million during the same period last year.
- Net loss for Q2 2024 amounted to $1.4 million, a significant decrease from $2.4 million in Q2 2023.
- Operating cash flow improved to a negative $0.6 million, compared to negative $1.9 million a year earlier.
- EBITDA for the quarter was reported at negative $1.1 million, an improvement from negative $2.0 million year over year.
- Adjusted EBITDA also showed improvement to negative $1.0 million from negative $1.7 million in Q2 2023.
Year-to-Date Financial Performance
For the six months ending June 30, 2024, ARCpoint demonstrated resilience with increased revenues and reduced losses.
YTD Financial Highlights
- Total revenues for the first half of 2024 reached $3.3 million, up from $3.2 million in the prior year.
- Net loss decreased to $2.9 million from $4.5 million a year earlier.
- Operating cash flow improved to negative $1.9 million, down from negative $3.1 million in the same period last year.
- Year-to-date EBITDA was reported at negative $2.2 million, compared to negative $3.8 million in 2023.
- Adjusted EBITDA also improved to negative $2.0 million from negative $2.8 million.
Company Overview
ARCpoint Inc. is a leading U.S.-based franchise system dedicated to providing accessible and affordable healthcare solutions through both technology and physical locations. The franchise operates over 130 independently owned labs across the U.S., offering a variety of health information services.
If you would like more information or wish to participate, please feel free to reach out to:
ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone: (604) 889-7827
E-mail: invest@arcpointlabs.com
Frequently Asked Questions
What is the purpose of the conference call hosted by ARCpoint?
The conference call is intended to discuss ARCpoint’s Q2 financial results and explore new opportunities arising from recent business developments.
Who is the CEO of ARCpoint?
The President and CEO of ARCpoint is John Constantine.
What financial improvements did ARCpoint achieve in Q2 2024?
ARCpoint reported increased revenues and a significant reduction in net loss compared to the previous year for Q2 2024.
What is MyARCpointLabs?
MyARCpointLabs is a technology platform designed to enhance service delivery for both ARCpoint franchisees and consumers.
How can I contact ARCpoint for more information?
You can reach ARCpoint through Jason Tong, Chief Financial Officer, by phone at (604) 889-7827 or via email at invest@arcpointlabs.com.
